2017
DOI: 10.1007/s40263-017-0439-7
|View full text |Cite
|
Sign up to set email alerts
|

Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 57 publications
0
4
0
Order By: Relevance
“…In comparisons of women exposed to lamotrigine with those unexposed, published studies estimated null or adverse effects on pregnancy duration and birth weight [14, 20, 23], protective or null effects on SGA [14, 20, 24], and null effects on head circumference [13, 20]. A recent systematic review that focused on lamotrigine concluded that there was no association between lamotrigine in monotherapy and congenital malformations, preterm delivery, or SGA [28, 29]; but a dose dependency was reported for congenital malformations. [5].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In comparisons of women exposed to lamotrigine with those unexposed, published studies estimated null or adverse effects on pregnancy duration and birth weight [14, 20, 23], protective or null effects on SGA [14, 20, 24], and null effects on head circumference [13, 20]. A recent systematic review that focused on lamotrigine concluded that there was no association between lamotrigine in monotherapy and congenital malformations, preterm delivery, or SGA [28, 29]; but a dose dependency was reported for congenital malformations. [5].…”
Section: Discussionmentioning
confidence: 99%
“…We conducted a cohort study based on nationwide Swedish register data from 1996 through 2013 to explore the association between maternal use of individual AEDs and pregnancy duration and fetal size. We chose lamotrigine as the reference AED because it is commonly used, providing a statistical advantage as well as a reasonable clinical comparison, and has been considered to have fewer adverse fetal effects than other AEDs based on information available at the time this study was conducted [2, 12, 28, 29].…”
Section: Methodsmentioning
confidence: 99%
“…In comparisons of women exposed to lamotrigine with those unexposed, published studies reported null or adverse effects on pregnancy duration and birth weight [14,20,23], protective or null effects on SGA [14,20,24], and null effects on head circumference [13,20]. A recent systematic review that focused on lamotrigine concluded that there was no association between lamotrigine in monotherapy and congenital malformations, preterm delivery, or SGA [28,29]; but a dose dependency was reported for congenital malformations. [5].…”
Section: Lamotriginementioning
confidence: 99%
“…Overview 90 We conducted a cohort study based on nationwide Swedish register data from 1996 through 2013 91 to explore the association between maternal use of individual AEDs and pregnancy duration and 92 fetal size. Lamotrigine was the reference AED because it is commonly used and has been 93 considered to have fewer adverse fetal effects than other AEDs [2,12,28,29]. 94 Data sources 95 In Sweden, tax-funded health care is provided to all citizens.…”
mentioning
confidence: 99%